Advertisement

Hirschsprung’s Disease: Pathogenesis and Overview

  • Hisayoshi Kawahara
Chapter

Abstract

Surgical options using various techniques of pull-through surgery have been performed in clinical practice as a consensus therapy for years, whereas the pathogenesis of Hirschsprung’s disease (HD) remains unclear. Among all of patients with HD, only 20% of cases were familial, and the majority of cases were sporadic with the normal genes associated with the enteric nervous system (ENS). The remaining 80% of sporadic cases highlights the need to understand the etiology and pathogenic mechanism of HD. There are two major theories that explain the pathogenesis of HD in children. One is nongenetic pathogeneses and the other is genetic. The nongenetic factors include the abnormalities in migration of neural crest cells (NCCs), microenvironment surrounding the NCCs, cell adhesion molecules, neurotrophic factors, immunologic response in utero, epithelial-derived signal, and autophagy. These abnormalities may be responsible for the innervation deficiency due to incomplete colonization of enteric NCCs in the gut. The other theory responsible for the pathogenesis of HD is the variety of gene mutations including ret. proto-oncogene (RET), glial cell-derived neurotrophic factor (GDNF), endothelin receptor B (EDNRB), sex-determining region Y-box 10 (SOX10), and so on. In this chapter, the pathogeneses of HD are overviewed based on literatures.

Keywords

Enteric nervous system Neural crest cell Migration Microenvironment Gene Ret proto-oncogene (RET

References

  1. 1.
    Dasgupta R, Langer JC. Hirschsprung disease. Curr Probl Surg. 2004;41:942–88.CrossRefGoogle Scholar
  2. 2.
    Hirschsprung H. Stuhltragheit Neugeborener infolge von Dilatation und Hypertrophie des Colons. Jahrb Kinderheilkd. 1887;27:1–42.Google Scholar
  3. 3.
    Tittel K. Uber eine angeborene Missbildung des Dickdrmes. Wien Klin Wochenschr. 1901;14:903–7.Google Scholar
  4. 4.
    Fraser J. Surgery of childhood. New York: William Wood and Company; 1926.Google Scholar
  5. 5.
    Ehrenpreis T. Megacolon in the newborn. A clinical and roentgenological study with special regard to pathogenesis. Acta Chir Scand Suppl. 1946;94:112.Google Scholar
  6. 6.
    Whitehouse FR, Kernohan JW. The myenteric plexus in congenital megacolon. Arch Intern Med. 1948;82:75–111.CrossRefGoogle Scholar
  7. 7.
    Swenson O, Rheinlander HF, Diamond I. Hirschsprung’s disease; a new concept of the etiology; operative results in 34 patients. N Engl J Med. 1949;241:551–6.CrossRefGoogle Scholar
  8. 8.
    Bolande R. The neurocristopathies: a unifying concept of disease arising in neural crest maldevelopment. Hum Pathol. 1974;5:409–29.CrossRefGoogle Scholar
  9. 9.
    Okamoto E, Ueda T. Embryogenesis of intramural ganglia of the gut and its relation to Hirschsprung’s disease. J Pediatr Surg. 1967;2:437–43.CrossRefGoogle Scholar
  10. 10.
    Le Douarin NM, Teillet M-A. The migration of neural crest cells to the wall of the digestive tract in avian embryo. J Embryol Exp Morphol. 1973;30:31–48.PubMedGoogle Scholar
  11. 11.
    Puri P, Shinkai T. Pathogenesis of Hirschsprung’s disease and its variants: recent progress. Semin Pediatr Surg. 2004;13:18–24.CrossRefGoogle Scholar
  12. 12.
    Webster W. Embryogenesis of the enteric ganglia in normal mice and in mice that develop congenital aganglionic megacolon. J Embryol Exp Morphol. 1973;30:573–85.PubMedGoogle Scholar
  13. 13.
    Tam PK, Boyd GP. Origin, course, and endings of abnormal enteric nerve fibres in Hirschsprung’s disease defined by whole-mount immunohistochemistry. J Pediatr Surg. 1990;25:457–61.CrossRefGoogle Scholar
  14. 14.
    Tam PK, Lister J. Developmental profile of neurone-specific enolase in human gut and its implications in Hirschsprung’s disease. Gastroenterology. 1986;90:1901–6.CrossRefGoogle Scholar
  15. 15.
    Gershon MD, Chalazonitis A, Rothman TP. From neural crest to bowel: development of the enteric nervous system. J Neurobiol. 1993;24:199–214.CrossRefGoogle Scholar
  16. 16.
    Allan IJ, Newgreen DF. The origin and differentiation of enteric neurons of the intestine of the fowl embryo. Am J Anat. 1980;157:137–54.CrossRefGoogle Scholar
  17. 17.
    Meijers JH, Tibboel D, van der Kamp AW, van Haperen-Heuts IC, Molenaar JC. A model for aganglionosis in the chicken embryo. J Pediatr Surg. 1989;24:557–61.CrossRefGoogle Scholar
  18. 18.
    Fujimoto T, Hata J, Yokoyama S, Mitomi T. A study of the extracellular matrix protein as the migration pathway of neural crest cells in the gut: analysis in human embryos with special reference to the pathogenesis of Hirschsprung’s disease. J Pediatr Surg. 1989;24:550–6.CrossRefGoogle Scholar
  19. 19.
    Burns AJ, Douarin NM. The sacral neural crest contributes neurons and glia to the post-umbilical gut: spatiotemporal analysis of the development of the enteric nervous system. Development. 1998;125:4335–47.PubMedGoogle Scholar
  20. 20.
    Kenny SE, Tam PK, Garcia-Barcelo M. Hirschsprung’s disease. Semin Pediatr Surg. 2010;19:194–200.CrossRefGoogle Scholar
  21. 21.
    Soret R, Mennetrey M, Bergeron KF, Dariel A, Neunlist M, Grunder F, Faure C, Silversides DW, Pilon N, Ente-Hirsch Study Group. A collagen VI-dependent pathogenic mechanism for Hirschsprung’s disease. J Clin Invest. 2015;125:4483–96.CrossRefGoogle Scholar
  22. 22.
    Kamagata S, Donahoe PK. The effect of fibronectin on cholinergic differentiation of the fetal colon. J Pediatr Surg. 1985;20:307–14.CrossRefGoogle Scholar
  23. 23.
    Pomeranz HD, Rothman TP, Chalazonitis A, Tennyson VM, Gershon MD. Neural crest-derived cells isolated from the gut by immunoselection develop neuronal and glial phenotypes when cultured on laminin. Dev Biol. 1993;156:341–61.CrossRefGoogle Scholar
  24. 24.
    Parikh DH, Tam PK, Van Velzen D, Edgar D. Abnormalities in the distribution of laminin and collagen type IV in Hirschsprung’s disease. Gastroenterology. 1992;102:1236–41.CrossRefGoogle Scholar
  25. 25.
    Payette RF, Tennyson VM, Pomeranz HD, Pham TD, Rothman TP, Gershon MD. Accumulation of components of basal laminae: association with the failure of neural crest cells to colonize the presumptive aganglionic bowel of ls/ls mutant mice. Dev Biol. 1988;125:341–60.CrossRefGoogle Scholar
  26. 26.
    Parikh DH, Tam PK, Van Velzen D, Edgar D. The extracellular matrix components, tenascin and fibronectin, in Hirschsprung’s disease: an immunohistochemical study. J Pediatr Surg. 1994;29:1302–6.CrossRefGoogle Scholar
  27. 27.
    Zheng Y, Lv X, Wang D, Gao N, Zhang Q, Li A. Down-regulation of fibronectin and the correlated expression of neuroligin in hirschsprung disease. Neurogastroenterol Motil. 2017;28  https://doi.org/10.1111/nmo.13134.
  28. 28.
    Langer JC, Betti PA, Blennerhassett MG. Smooth muscle from aganglionic bowel in Hirschsprung’s disease impairs neuronal development in vitro. Cell Tissue Res. 1994;276:181–6.CrossRefGoogle Scholar
  29. 29.
    Puri P, Ohshiro K, Wester T. Hirschsprung’s disease: a search for etiology. Semin Pediatr Surg. 1998;7:140–7.CrossRefGoogle Scholar
  30. 30.
    Romanska HM, Bishop AE, Brereton RJ, Spitz L, Polak JM. Increased expression of muscular neural cell adhesion molecule in congenital aganglionosis. Gastroenterology. 1993;105:1104–9.CrossRefGoogle Scholar
  31. 31.
    Kobayashi H, O’Briain DS, Puri P. Lack of expression of NADPH-diaphorase and neural cell adhesion molecule (NCAM) in colonic muscle of patients with Hirschsprung’s disease. J Pediatr Surg. 1994;29:301–4.CrossRefGoogle Scholar
  32. 32.
    Ikawa H, Kawano H, Takeda Y, Masuyama H, Watanabe K, Endo M, Yokoyama J, Kitajima M, Uyemura K, Kawamura K. Impaired expression of neural cell adhesion molecule L1 in the extrinsic nerve fibers in Hirschsprung’s disease. J Pediatr Surg. 1997;32:542–5.CrossRefGoogle Scholar
  33. 33.
    Takenouchi T, Nakazawa M, Kanemura Y, Shimozato S, Yamasaki M, Takahashi T, Kosaki K. Hydrocephalus with Hirschsprung disease: severe end of X-linked hydrocephalus spectrum. Am J Med Genet A. 2012;158A:812–5.CrossRefGoogle Scholar
  34. 34.
    Kuroda T, Ueda M, Nakano M, Saeki M. Altered production of nerve growth factor in aganglionic intestines. J Pediatr Surg. 1994;29:288–92.CrossRefGoogle Scholar
  35. 35.
    Sánchez MP, Silos-Santiago I, Frisén J, He B, Lira SA, Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 1996;382:70–3.CrossRefGoogle Scholar
  36. 36.
    Martucciello G, Thompson H, Mazzola C, Morando A, Bertagnon M, Negri F, Brizzolara A, Rocchetti L, Gambini C, Jasonni V. GDNF deficit in Hirschsprung’s disease. J Pediatr Surg. 1998;33:99–102.CrossRefGoogle Scholar
  37. 37.
    Ohshiro K, Puri P. Reduced glial cell line-derived neurotrophic factor level in aganglionic bowel in Hirschsprung’s disease. J Pediatr Surg. 1998;33:904–8.CrossRefGoogle Scholar
  38. 38.
    Kusafuka T, Puri P. Altered RET gene mRNA expression in Hirschsprung’s disease. J Pediatr Surg. 1997;32:600–4.CrossRefGoogle Scholar
  39. 39.
    Iwashita T, Kruger GM, Pardal R, Kiel MJ, Morrison SJ. Hirschsprung disease is linked to defects in neural crest stem cell function. Science. 2003;301:972–6.CrossRefGoogle Scholar
  40. 40.
    O’Donnell AM, Coyle D, Puri P. Decreased expression of NEDL2 in Hirschsprung’s disease. J Pediatr Surg. 2016;51:1839–42.CrossRefGoogle Scholar
  41. 41.
    Facer P, Knowles CH, Thomas PK, Tam PK, Williams NS, Anand P. Decreased tyrosine kinase C expression may reflect developmental abnormalities in Hirschsprung’s disease and idiopathic slow-transit constipation. Br J Surg. 2001;88:545–52.CrossRefGoogle Scholar
  42. 42.
    Hirobe S, Doody DP, Ryan DP, Kim SH, Donahoe PK. Ectopic class II major histocompatibility antigens in Hirschsprung’s disease and neuronal intestinal dysplasia. J Pediatr Surg. 1992;27:357–62.CrossRefGoogle Scholar
  43. 43.
    Kobayashi H, Hirakawa H, Puri P. Overexpression of intercellular adhesion molecule-1 (ICAM-1) and MHC class II antigen on hypertrophic nerve trunks suggests an immunopathologic response in Hirschsprung’s disease. J Pediatr Surg. 1995;30:1680–3.CrossRefGoogle Scholar
  44. 44.
    Moore SW, Johnson G, Schneider JW. Elevated tissue immunoglobulins in Hirschsprung’s disease—indication of early immunologic response. Eur J Pediatr Surg. 2000;10:106–10.CrossRefGoogle Scholar
  45. 45.
    Sukegawa A, Narita T, Kameda T, Saitoh K, Nohno T, Iba H, Yasugi S, Fukuda K. The concentric structure of the developing gut is regulated by Sonic hedgehog derived from endodermal epithelium. Development. 2000;127:1971–80.PubMedGoogle Scholar
  46. 46.
    Fu M, Lui VC, Sham MH, Pachnis V, Tam PK. Sonic hedgehog regulates the proliferation, differentiation, and migration of enteric neural crest cells in gut. J Cell Biol. 2004;166:673–84.CrossRefGoogle Scholar
  47. 47.
    Nagy N, Barad C, Graham HK, Hotta R, Cheng LS, Fejszak N, Goldstein AM. Sonic hedgehog controls enteric nervous system development by patterning the extracellular matrix. Development. 2016;143:264–75.CrossRefGoogle Scholar
  48. 48.
    Jiang Y, Liu MT, Gershon MD. Netrins and DCC in the guidance of migrating neural crest-derived cells in the developing bowel and pancreas. Dev Biol. 2003;258:364–84.CrossRefGoogle Scholar
  49. 49.
    Huang Q, Ge X, Li P, Duan Y, Guo Z, Zheng B, Wu X, Guo X, Gao Y. Detection of autophagy in Hirschsprung’s disease: implication for its role in aganglionosis. Neuroreport. 2015;26:1044–50.CrossRefGoogle Scholar
  50. 50.
    Ge X, Hu C, Guo Q, Li W, Zhao Y, Yang W, Wang Y, Li P, Gao Y, Huang Q. Investigation of the expression of apoptosis-inducing factor-mediated apoptosis in Hirschsprung’s disease. Neuroreport. 2017;28:571–8.CrossRefGoogle Scholar
  51. 51.
    Goldstein AM, Thapar N, Karunaratne TB, De Giorgio R. Clinical aspects of neurointestinal disease: pathophysiology, diagnosis, and treatment. Dev Biol. 2016;417:217–28.CrossRefGoogle Scholar
  52. 52.
    Gabriel SB, Salomon R, Pelet A, Angrist M, Amiel J, Fornage M, Attié-Bitach T, Olson JM, Hofstra R, Buys C, Steffann J, Munnich A, Lyonnet S, Chakravarti A. Segregation at three loci explains familial and population risk in Hirschsprung disease. Nat Genet. 2002;31:89–93.CrossRefGoogle Scholar
  53. 53.
    Hofstra RM, Wu Y, Stulp RP, Elfferich P, Osinga J, Maas SM, Siderius L, Brooks AS, vd Ende JJ, Heydendael VM, Severijnen RS, Bax KM, Meijers C, Buys CH. RET and GDNF gene scanning in Hirschsprung patients using two dual denaturing gel systems. Hum Mutat. 2000;15:418–29.CrossRefGoogle Scholar
  54. 54.
    Emison ES, McCallion AS, Kashuk CS, Bush RT, Grice E, Lin S, Portnoy ME, Cutler DJ, Green ED, Chakravarti A. A common sex-dependent mutation in a RET enhancer underlies Hirschsprung disease risk. Nature. 2005;434:857–63.CrossRefGoogle Scholar
  55. 55.
    Griseri P, Lantieri F, Puppo F, Bachetti T, Di Duca M, Ravazzolo R, Ceccherini I. A common variant located in the 3′UTR of the RET gene is associated with protection from Hirschsprung disease. Hum Mutat. 2007;28:168–76.CrossRefGoogle Scholar
  56. 56.
    Goldstein AM, Hofstra RM, Burns AJ. Building a brain in the gut: development of the enteric nervous system. Clin Genet. 2013;83:307–16.CrossRefGoogle Scholar
  57. 57.
    Carrasquillo MM, McCallion AS, Puffenberger EG, Kashuk CS, Nouri N, Chakravarti A. Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease. Nat Genet. 2002;32:237–44.CrossRefGoogle Scholar
  58. 58.
    Cantrell VA, Owens SE, Chandler RL, Airey DC, Bradley KM, Smith JR, Southard-Smith EM. Interactions between Sox10 and EdnrB modulate penetrance and severity of aganglionosis in the Sox10Dom mouse model of Hirschsprung disease. Hum Mol Genet. 2004;13:2289–301.CrossRefGoogle Scholar
  59. 59.
    Heuckeroth RO, Schäfer KH. Gene-environment interactions and the enteric nervous system: Neural plasticity and Hirschsprung disease prevention. Dev Biol. 2016;417:188–97.CrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Hisayoshi Kawahara
    • 1
  1. 1.Department of Pediatric SurgeryHamamatsu University School of MedicineHamamatsuJapan

Personalised recommendations